Tuesday, 31 July 2018

Cervical Cancer Early Detection Program of Prodia - BPJS Kesehatan 2018

In Indonesia, cervical cancer is the second most common cause of cancer for women. The number of new cervical cancer cases and deaths it causes keeps increasing each year.

This is ironic because cervical cancer is actually the most preventable one among all cancers, provided that it has been detected at the earliest stage.

Thus, the government, in this case the Ministry of Health of the Republic of Indonesia, sustainably develops a cervical cancer early detection program across Indonesia.

Prodia Clinical Laboratory in collaboration with the Healthcare and Social Security Agency (BPJS Kesehatan) hold a free Pap smear event for the 'active' participants of BPJS Kesehatan during August-December 2018 with the following conditions:

  1. The free Pap smear only applies at some branches of Prodia Clinical Laboratory*) with different periods of implementation and will be closed once the quota is full. Therefore, please ensure the availability of the free Pap smear first at the branches of Prodia Clinical Laboratory*) that serve the free Pap smear.
  2. The participants must be women holding a BPJS Kesehatan/Askes/National Health Insurance card or Indonesia Health Cards (KIS) with 'active' (in-force) membership status.
  3. The participants must bring the BPJS Kesehatan/Askes/National Health Insurance card or Indonesia Health Card (KIS) and the identity card (both the original and the copy).
  4. The participants never have the Pap smear administered by BPJS before or already had the Pap smear from BPJS within more than 1 year (those having Pap smear program from BPJS in less than 1 year are not included).
  5. The participants must complete the Pap smear preparation standardized by Prodia Clinical Laboratory, which requires the participants to be:
  • Married/already having had sexual intercourse
  • Not pregnant
  • Not in a period (better conducted on the 14th day after the first day of menstruation)
  • Not taking tampon, jelly, vaginal cream, nor any drugs inserted through the vagina within 2 days (48 hours) prior to the test
  • Not washing the vagina using vaginal cleansing fluid within 2 days (48 hours) prior to the test
  • Not having sexual intercourse within 1 day (24 hours) prior to the test
  • Fulfilling the Pap smear willingness form (will be given at the test location)

To see the list of branches of Prodia Clinical Laboratory that hold the free Pap smear 2018, click here.

For further information, please contact Prodia branches or Contact Prodia at 1-500-830.


What is a Pap smear?

Cervix is the female sexual organ most likely exposed to diseases. The most dangerous one is the infection of virus causing cervical cancer, namely human papillomavirus (HPV). The most effective method to prevent cervical cancer is through early detection using a regular Pap smear test.

What is cervical cancer?

Cervical cancer is a severity taking place at the cervix, which is the lowermost portion of the uterus that protrudes into the vagina. The cause is yet indefinite, but the positive HPV is found in 95% of the cases. Cervical cancer is the foremost cause of death among all cancers.

What are the symptoms?

Generally no single symptom occurs at the early stage. When occurs, it is in form of unusual vaginal discharge. At the advanced stage, the symptoms can be:

  • Vaginal bleeding after intercourse
  • Foul smelling vaginal discharge
  • Vaginal bleeding between periods
  • Vaginal bleeding after menopause
  • Pelvic pain.

What are the risk factors?

  • Having early sexual intercourse (under 17 years old).
  • Having multiple sexual partners and having sexual intercourse with men who also frequently change sexual partners.
  • Having history of frequent genital infection.
  • Giving birth frequently.
  • Smoking women are two times more likely to have this disease rather than the non-smokers.

What is the purpose of a Pap smear?

This test aims at identifying the presence of HPV or carcinoma cells, which are the causes of cervical cancer.